Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)

乳腺癌幸存者的超长期神经认知结果(ProbC2)

基本信息

  • 批准号:
    10558447
  • 负责人:
  • 金额:
    $ 31.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Chemotherapy-related cognitive impairment (CRCI) is associated with reduced quality of life and survival making it a significant problem that remains understudied. Research by our group and others has demonstrated that CRCI is associated with altered brain structure and function from pretreatment to post treatment. There is significant overlap between chemotherapy actions and physiologic processes involved in aging. Neurocognitive have been found in patients up to 20+ years post- treatment and work by our group and others suggests an accelerated brain aging phenotype in breast cancer survivors treated with chemotherapy. We have also observed that patients may demonstrate unique trajectories of cognitive impairment that require further study. Existing prospective, longitudinal studies of cancer and cognition, including our own, have been limited to relatively short-term post- treatment follow-ups (e.g. 6-12 months). To begin addressing these limitations, we aim to extend our current prospective study (CA172145), which longitudinally examines cognitive function and brain structure/function pre-surgery, 1-month post chemotherapy, and 1-year post chemotherapy. We will continue to assess cohorts of women treated with chemotherapy, chemotherapy naïve patients, and healthy controls at yearly intervals for 5 additional years (up to 10 years). Using non-invasive neuroimaging methods, we will advance our original aims from the initial project to measure very long- term neurobiologic outcomes with an emphasis on the assessment of neural connectivity rather than specific regional changes (Aim 1). We will also examine very long-term cognitive outcomes as measured by standardized neuropsychological testing (Aim 2). Finally, we will explore different trajectories or subtypes of impairment and their neural phenotypes (Aim 3). The proposed project will significantly advance the understanding of chemotherapy-related cognitive impairments by extending our knowledge on very long-term neurobiological outcomes along with the different subtypes of cognitive impairments and associated neural profiles following breast cancer chemotherapy.
项目总结/摘要 化疗相关的认知功能障碍(CRCI)与生活质量降低相关, 生存使其成为一个尚未充分研究的重要问题。我们小组和其他人的研究 已经证明CRCI与治疗前脑结构和功能的改变有关, 后处理。化疗作用和生理作用之间存在显著重叠, 参与衰老的过程。神经认知已经在患者中发现, 我们小组和其他人的治疗和工作表明,乳腺癌患者的大脑老化表型加速, 接受化疗的癌症幸存者我们还观察到,患者可能会表现出 认知障碍的独特轨迹需要进一步研究。现有的前瞻性、纵向 癌症和认知的研究,包括我们自己的,一直局限于相对短期的后, 治疗随访(例如6-12个月)。为了开始解决这些限制,我们的目标是扩展我们的 目前的前瞻性研究(CA 172145),纵向检查认知功能和大脑 术前、化疗后1个月和化疗后1年的结构/功能。我们将 继续评估接受化疗的女性、化疗初治患者队列, 健康对照组,每年一次,持续5年(最多10年)。使用非侵入性 神经影像学方法,我们将推进我们最初的目标,从最初的项目,以衡量很长的- 长期神经生物学结果,重点是评估神经连接,而不是 具体区域变化(目标1)。我们还将研究非常长期的认知结果, 通过标准化神经心理学测试(Aim 2)测量。最后,我们将探索不同的 损伤的轨迹或亚型及其神经表型(目标3)。拟议项目将 通过扩展,显着推进对化疗相关认知障碍的了解 我们对不同亚型的非常长期的神经生物学结果沿着的知识 乳腺癌化疗后的认知障碍和相关神经特征。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oxana G Palesh其他文献

Oxana G Palesh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oxana G Palesh', 18)}}的其他基金

Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)
乳腺癌幸存者的超长期神经认知结果(ProbC2)
  • 批准号:
    10643569
  • 财政年份:
    2022
  • 资助金额:
    $ 31.52万
  • 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
  • 批准号:
    10642316
  • 财政年份:
    2022
  • 资助金额:
    $ 31.52万
  • 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
  • 批准号:
    10591478
  • 财政年份:
    2022
  • 资助金额:
    $ 31.52万
  • 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
  • 批准号:
    9916223
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
Efficacy of Brief Behavioral Therapy for Cancer-Related Insomnia in Reducing Headache Burden: Exploring Patient Phenotypes and Predictors of Response
简短行为疗法治疗癌症相关失眠在减轻头痛负担方面的功效:探索患者表型和反应预测因子
  • 批准号:
    10302033
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
Brief Behavioral Intervention for Insomnia During Chemotherapy
化疗期间失眠的简短行为干预
  • 批准号:
    8720244
  • 财政年份:
    2014
  • 资助金额:
    $ 31.52万
  • 项目类别:
Brief Behavioral Intervention for Insomnia During Chemotherapy
化疗期间失眠的简短行为干预
  • 批准号:
    9276643
  • 财政年份:
    2014
  • 资助金额:
    $ 31.52万
  • 项目类别:
Management of Insomnia in Cancer Patients
癌症患者失眠的治疗
  • 批准号:
    7694412
  • 财政年份:
    2008
  • 资助金额:
    $ 31.52万
  • 项目类别:
Management of Insomnia in Cancer Patients
癌症患者失眠的治疗
  • 批准号:
    8137044
  • 财政年份:
    2008
  • 资助金额:
    $ 31.52万
  • 项目类别:
Management of Insomnia in Cancer Patients
癌症患者失眠的治疗
  • 批准号:
    7923095
  • 财政年份:
    2008
  • 资助金额:
    $ 31.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了